Hubei Guangji Pharmaceutical Co., Ltd.
000952.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.3B
Close$
Share Statistics
| Market cap | $2.30 Billion |
|---|---|
| Enterprise Value | $3.43 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.16 |
| Beta | 0.25 |
| Outstanding Shares | 346,750,339 |
Return
| Return on Equity | -64.74% |
|---|---|
| Return on Assets | -17.77% |
| Return on Invested Capital | -54.50% |
Valuation & Multiples
| P/E Ratio | -6.03 |
|---|---|
| PEG | 18.27 |
| Price to Sales | 6.44 |
| Price to Book Ratio | 6.44 |
| Enterprise Value to Revenue | 5.26 |
| Enterprise Value to EBIT | -8.96 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.41 |
| Debt to Equity | 2.33 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hubei Guangji Pharmaceutical Co., Ltd.
1,164 employees
CEO: Cheng Gong Hubei Guangji Pharmaceutical Co., Ltd. engages in the production and operation of pharmaceutical raw materials, pharmaceutical preparations, and feed additives. It specializes in production of vitamin B2, B6 and pharmaceutical products. ...